Lipocine Inc. Earnings Per Share Diluted

• Lipocine Inc. showed an increase of +46.2% in Earnings Per Share Diluted from 2023 to 2025.
• This data is from Lipocine Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
• XBRL data for this metric is available from 2012 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 13 years of available data (2012 to 2025), Lipocine Inc.'s Earnings Per Share Diluted has declined by 298.8%.
• Historical annual values: Fiscal year 2025: $1.69 (loss) per share | Fiscal year 2023: $3.14 (loss) per share | Fiscal year 2022: $2.15 (loss) per share | Fiscal year 2021: $0.01 (loss) per share | Fiscal year 2020: $0.38 (loss) per share | Fiscal year 2019: $0.50 (loss) per share | Fiscal year 2018: $0.55 (loss) per share | Fiscal year 2017: $1.05 (loss) per share | Fiscal year 2016: $1.04 (loss) per share | Fiscal year 2015: $1.11 (loss) per share | Fiscal year 2014: $1.60 (loss) per share | Fiscal year 2013: $1.44 (loss) per share | Fiscal year 2012: $0.85 per share.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026